Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine
 Disease Category: COPD (Chronic Obstructive Pulmonary Disease)
Location: United States, NC

Trial Information

12 week study for patients with COPD

The purpose of this study is to assess the effectiveness of treatment with Respimat and Spiriva compared to Spiriva alone on lung function in patients with COPD.

Patient Inclusion Criteria:

  • Age 40+
  • Current or ex-smokers with at least a 10 year pack smoking history

Patient Exclusion Criteria:

  • Patients who use oxygen therapy for more than 1 hour each day (oxygen during night is allowed)
  • Heart attack within the past year
  • Malignancy within the past 5 years

Mary Preisel, Marketing/Clinical Research Coordinator
American Health Research
1918 Randolph Rd, Suite 440
Charlotte, NC 28207
Phone: 704-325-6700
Fax: 704-926-8048
Email: Mpreisel@ahres.com

View Map

Research Center Information: American Health Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.